Navigation Links
Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting

r of the UCLA Hepatology Clinical Research Center, will present "Telbivudine Globe Trial at Year Two: Efficacy, Safety, and Predictors of Outcome in Patients with Chronic Hepatitis B" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Steven Han will also present "Hepatitis B Patient Survey: Disease Understanding and Compliance in the United States" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Natalie Bzowej, Director of Clinical Hepatology Research at California Pacific Medical Center, will present "A Randomized Trial of Telbivudine vs. Adefovir for HBeAg-Positive Chronic Hepatitis B: Efficacy Through Week 76, Predictors of Response and Effects of Switching to Telbivudine" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Elizabeth J. Heathcote, Professor of Medicine at the University of Toronto Western Hospital, will present "Salvage Therapy with Adefovir for Virologic Breakthrough in Telbivudine-Treated Patients from the GLOBE Study" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Yuming Wang, Professor of Infectious Disease, Southwest Hospital, Chongqing, China, will present "A Phase III Comparative Trial of Telbivudine vs Lamivudine in Chinese Patients with Chronic Hepatitis B: Two- Year Results" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Vinod Rustgi, Co-Director of the Transplant Institute at Georgetown University School of Medicine and Clinical Professor of Medicine at the Medical College of Virginia, will present "A Survey of Hepatitis B Patient Demographics, Disease Characteristics and Management Practice in the United States" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. Xiao-Jian Zhou, Director, Clinical Pharmacology at Idenix Pharmaceuticals, will present "Absence of Pharmacokinetic Drug-Drug Interaction Between Telbivudine and Tenofovir" in
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3
... patients at Beaumont,Hospitals are the first in the world ... that is painless, faster, more accurate and precise,than other ... the new,technology, Omnibeam(R). The $3.3-million machine is manufactured in,England ... patient,was treated on Sept. 10. The painless treatment ...
... Pharmaceuticals,Inc. (Amex: KAL; FWB: CA4), a developer of ... gastrointestinal disorders and diseases, announced today,that complete enrollment ... to,treat low to intermediate grade neuroendocrine carcinoma (advanced,carcinoid ... designed,to enroll 40 patients, presently has patients enrolled ...
Cached Medicine Technology:Beaumont Patients 1st to get Next Generation of Radiation Treatment 2Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer 2Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer 3Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer 4
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... with the healthcare sector have benefited the Massage ... Given the discretionary characteristics of industry products, the anticipated ... the five-year period has provided consumers with the means ... adults that have received a massage in a given ...
(Date:12/20/2014)... The print component of Healthy Aging is distributed within ... copies and an estimated readership of 420,000. The digital ... strategy and across a network of top news sites ... the campaign, click here . , The publication ... CTV’s The Social. Lainey Lui, Melissa Grelo, Traci ...
(Date:12/20/2014)... 2014 The Doctor’s Office Urgent Care of ... part of a decade. They’ve treated over 40,000 patients ... healthcare alternative to the Paramus area. , ... additions to their staff of top-notch board certified physicians: Christine ... These new doctors will work tirelessly to carry ...
(Date:12/20/2014)... Atore, Inc, (San Francisco, CA CEO: Masashi ... focused portal on December 17th, 2014. , One ... US and Japan. , MERRY BIRTHDAY SITE : ... , MERRY BIRTHDAY MESSAGE is part of 5 future ... Features, Choose from thousands of stock photos to decorate ...
(Date:12/20/2014)... December 20, 2014 Developers of ... of a new plugin for Final Cut Pro X ... “TranSlice Volume 5 allows users to create hand drawn ... Said Christina Austin, CEO of Pixel Film Studios. “TranSlice ... professionalism while maintaining an easy to use interface.” , ...
Breaking Medicine News(10 mins):Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... of Innovation in ... Provider, SILVER SPRING, Md. and CAMBRIDGE, Mass., ... for Medical Simulation (CMS) today,announced that they are ... facility,s already cutting edge simulation programs.,B-Line Medical will ...
... Inc.,(Nasdaq: CYNO ), a leading developer and ... systems, today announced that the company,will present at ... New York,City. Chief Financial Officer Timothy Baker ... financial results in a presentation,beginning at 1:30 p.m. ...
... DEL MAR, Calif., Sept. 10 "Portuguese speaking,Brazil ... surgery," claims Dr.,Barry L. Friedberg. In recognition of ... book, is now scheduled for,a Portuguese translation after ... University Press. Knowledge acquired in this book will,empower ...
... marketing campaign celebrates Freedom to Breathe Act, ... of a,new marketing campaign designed to educate and ... statewide smoke-free law that goes into effect,on October ... workplaces smoke-free,including bars, restaurants and private clubs. Called ...
... healthy women, breast cancer survivors reported more days of ... in the October 15, 2007 issue of CANCER, a ... who received both chemotherapy and radiotherapy reported the most ... complaint in the general population and, anecdotally, common among ...
... be deadly for skiers, mountain climbers, regardless of fitness , ... high altitude pulmonary edema (HAPE) -- a life-threatening buildup of ... -- has been launched at the University of Edinburgh in ... at altitudes as low as 2,500 meters and can affect ...
Cached Medicine News:Health News:B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership 2Health News:B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership 3Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Cosmetic Surgery & Exotic Brazil 2Health News:Fresh Air Campaign to Showcase Minnesotans' Love of Smoke-Free Air 2Health News:Chemotherapy may be culprit for fatigue in breast cancer survivors 2
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia....
STABIBAG Hydrophilic Acrylic Lens....
BIGBAG Hydrophilic Acrylic Lens for high myopia....
One piece multifocal acrylic intraocular lens....
Medicine Products: